have invented an oral formulation of arsenic trioxide (Oral-ATO; ARSENOL) for the treatment of acute promyelocytic leukemia (APL), a blood cancer that once had a high fatality rate. The invention ...

APL was once a highly fatal disease, with up to 30% of patients dying early from complications. Traditional treatments often ...